Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice

Biochemical and Biophysical Research Communications

Volumn 432, Issue 3, 2013, Pages 526-532

  Ohara, Arihisa ^a   Kasahara, Yoshiyuki ^a   Yamamoto, Hideko ^b   Hata, Harumi ^a   Kobayashi, Hideaki ^a   Numachi, Yohtaro ^a   Miyoshi, Ichiro ^a   Hall, F Scott ^c   Uhl, George R ^c   Ikeda, Kazutaka ^b   Sora, Ichiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dopamine; Locomotion; Monoamine; Transgenic

Indexed keywords

VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH; CONTROLLED STUDY; GROWTH RETARDATION; HOMOZYGOSITY; HUMAN; LETHALITY; LIFE EXTENSION; MONOAMINERGIC SYSTEM; MORBIDITY; MOUSE; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; TRANSGENIC MOUSE;

ADRENERGIC NEURONS; ANIMALS; ATAXIA; GAIT; LONGEVITY; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; TRANSGENES; VESICULAR MONOAMINE TRANSPORT PROTEINS;

MUS; MUS MUSCULUS;

EID: 84874963874     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.014     Document Type: Article

References (24)

1. Henry J.P., Sagne C., Bedet C., Gasnier B. The vesicular monoamine transporter: from chromaffin granule to brain. Neurochem. Int. 1998, 32:227-246.
2. Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., Edwards R.H. Differential expression of two vesicular monoamine transporters. J. Neurosci. 1995, 15:6179-6188.
3. Eiden L.E., Weihe E. VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann. N.Y. Acad. Sci. 2011, 1216:86-98.
4. Takahashi N., Miner L.L., Sora I., Ujike H., Revay R.S., Kostic V., Jackson-Lewis V., Przedborski S., Uhl G.R. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc. Natl. Acad. Sci. USA 1997, 94:9938-9943.
5. Truong J.G., Wilkins D.G., Baudys J., Crouch D.J., Johnson-Davis K.L., Gibb J.W., Hanson G.R., Fleckenstein A.E. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. J. Pharmacol. Exp. Ther. 2005, 314:1087-1092.
6. Uhl G.R., Li S., Takahashi N., Itokawa K., Lin Z., Hazama M., Sora I. The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins. FASEB J. 2000, 14:2459-2465.
7. Wang Y.M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B., Miller G.W., Wightman R.M., Caron M.G. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 1997, 19:1285-1296.
8. Hall F.S., Sora I., Uhl G.R. Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacol. 2003, 28:620-628.
9. Fukushima S., Shen H., Hata H., Ohara A., Ohmi K., Ikeda K., Numachi Y., Kobayashi H., Hall F.S., Uhl G.R., Sora I. Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. J. Psychopharmacol. 2007, 193:55-62.
10. Itokawa K., Sora I., Schindler C.W., Itokawa M., Takahashi N., Uhl G.R. Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden death. Brain Res. Mol. Brain Res. 1999, 71:354-357.
11. Weihe E., Schafer M.K., Erickson J.D., Eiden L.E. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 1994, 5:149-164.
12. Surratt C.K., Persico A.M., Yang X.D., Edgar S.R., Bird G.S., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., Uhl G.R. A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs. FEBS Lett. 1993, 318:325-330.
13. Kobayashi K., Morita S., Sawada H., Mizuguchi T., Yamada K., Nagatsu I., Fujita K., Kreitman R.J., Pastan I., Nagatsu T. Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. Proc. Natl. Acad. Sci. USA 1995, 92:1132-1136.
14. Cyr M., Beaulieu J.M., Laakso A., Sotnikova T.D., Yao W.D., Bohn L.M., Gainetdinov R.R., Caron M.G. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc. Natl. Acad. Sci. USA 2003, 100:11035-11040.
15. Klapdor K., Dulfer B.G., Hammann A., Van der Staay F.J. A low-cost method to analyse footprint patterns. J. Neurosci. Methods 1997, 75:49-54.
16. Fon E.A., Pothos E.N., Sun B.C., Killeen N., Sulzer D., Edwards R.H. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 1997, 19:1271-1283.
17. Knab A.M., Bowen R.S., Hamilton A.T., Gulledge A.A., Lightfoot J.T. Altered dopaminergic profiles: implications for the regulation of voluntary physical activity. Behav. Brain Res. 2009, 204:147-152.
18. Hunyady B., Palkovits M., Mezey E. Vesicular monoamine transporters in the rat stomach. J. Physiol. Paris 2000, 94:123-130.
19. Watson F., Kiernan R.S., Deavall D.G., Varro A., Dimaline R. Transcriptional activation of the rat vesicular monoamine transporter 2 promoter in gastric epithelial cells: regulation by gastrin. J. Biol. Chem. 2001, 276:7661-7671.
20. Anlauf M., Eissele R., Schafer M.K., Eiden L.E., Arnold R., Pauser U., Kloppel G., Weihe E. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J. Histochem. Cytochem. 2003, 51:1027-1040.
21. Bossé R., Fumagalli F., Jaber M., Giros B., Gainetdinov R.R., Wetsel W.C., Missale C., Caron M.G. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 1997, 19:127-138.
22. Pogorelov V.M., Rodriguiz R.M., Insco M.L., Caron M.G., Wetsel W.C. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 2005, 30:1818-1831.
23. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J. Neurosci. 2001, 21:305-313.
24. Patel J., Mooslehner K.A., Chan P.M., Emson P.C., Stamford J.A. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J. Neurochem. 2003, 85:898-910.